18 reports

Binge Eating Disorder (Central Nervous System) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Binge Eating Disorder - Drugs In Development, 2021, provides an overview of the Binge Eating Disorder (Central Nervous System) pipeline landscape. Binge...

  • Eating Disorder
  • Drug Development
  • World
  • Drug Approval
  • Dropout Rate

Binge Eating Disorder - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Binge Eating Disorder - Pipeline Review, H2 2020, provides an overview of the Binge Eating Disorder (Central Nervous System) pipeline landscape. Binge eating disorder...

  • Eating Disorder
  • World
  • Drug Approval
  • Dropout Rate

Binge Eating Disorder - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Binge Eating Disorder - Pipeline Review, H1 2020, provides an overview of the Binge Eating Disorder (Central Nervous System) pipeline landscape. Binge eating disorder...

  • Eating Disorder
  • World
  • Drug Approval
  • Dropout Rate

‘Anorexia Nervosa (AN)- Epidemiology Forecast–2032’ report delivers an in-depth understanding of AN, historical and forecasted epidemiology as well as AN trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan. Anorexia Nervosa Disease Understanding Anorexia nervosa (AN)...

  • Eating Disorder
  • Spain
  • Japan
  • Germany
  • United States
  • United Kingdom
  • France
  • Italy

‘Anorexia nervosa-Market Insights, Epidemiology, and Market Forecast–2032’ report deliver an in-depth understanding of the anorexia nervosa, historical and forecasted epidemiology as well as the anorexia nervosa market trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan. The anorexia nervosa...

  • Eating Disorder
  • United States
  • Spain
  • Japan
  • Germany
  • United Kingdom
  • France
  • Italy
  • Depression Prevalence

On the mend: A rebounding economy will likely support industry revenue growth Abstract Eating Disorder Clinics The Eating Disorder Clinics industry has experienced increased demand over the five years to 2019, alongside rising incidence of eating disorders in the United States. While there has been...

  • Eating Disorder
  • United States
  • Disposable Income
  • Employment Income

The 2020 Binge Eating Disorder pipeline report presents a comprehensive overview of the research and development of Binge Eating Disorder drug candidates. It presents drugs in development that could potentially reach the market in the next 5 to 10 years: One drug in Research phase, five drugs in pre-clinical phase, two drugs in Phase 1, one...

  • Eating Disorder
  • Drug Development
  • World
  • Number Of Enterprises

Orexin Receptor Type 1 - Drugs In Development, 2021 Summary Orexin Receptor Type 1 (Hypocretin Receptor Type 1 or HCRTR1) - Orexin receptor type 1 (Ox1R or OX1) is a protein that is encoded by the HCRTR1 gene. The orexin 1 receptor (OX1) is a G-protein coupled receptor that is highly expressed in...

  • Pharmaceutical
  • Therapy
  • Drug Development
  • Eating Disorder
  • World
  • Illicit Drug Use
  • Drug Approval

High levels of pipeline activity are being observed in Binge Eating Disorder treatment during 2019. Clinical development activities are being undertaken by more than 10 companies including Amygdala Neurosciences Inc, Chronos Therapeutics Ltd, F. Hoffmann-La Roche Ltd, Sosei Heptares, Novo Nordisk AS and others. A Significant contribution...

  • Eating Disorder
  • Clinical Trial
  • World
  • Drug Approval

The ongoing clinical trial research report- “2019 Binge Eating Disorder Ongoing Clinical Trials Study” analyzes the current scenario of all active Binge Eating Disorder trials across the world. The report presents top level analysis of global Binge Eating Disorder clinical trials across countries, companies and universities. It is designed...

  • Eating Disorder
  • Clinical Trial
  • World
  • APAC

10 Companies Make Active Investments in Binge Eating Disorder Pipeline Drugs The global demand for Binge Eating Disorder treatment options is emerging rapidly driven by demand in major emerging and developed markets. An increasing number of companies are working on Binge Eating Disorder pipeline. Companies quickly adapting to the new...

  • Eating Disorder
  • World
  • Number Of Enterprises

The global clinical trial report- “2019 Binge Eating Disorder Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Binge Eating Disorder. It presents in-depth analysis of Binge Eating Disorder clinical trials across markets and companies. The research work is for providing complete understanding into trends...

  • Eating Disorder
  • Clinical Trial
  • World

Comprehensive Pipeline Review on Ongoing Clinical and Pre-clinical studies Binge Eating Disorder Drug Development Pipeline Study is the latest publication from VPA Research with comprehensive information of Binge Eating Disorder pipeline products. The Binge Eating Disorder pipeline guide presents complete overview of drugs currently...

  • Eating Disorder
  • World

Binge Eating Disorder (BED): Epidemiology Forecast to 2027 Summary In 2017, the 7MM had 197,076 diagnosed prevalent cases of Binge Eating Disorder (BED). Epidemiologists expect the diagnosed prevalent cases of Binge Eating Disorder (BED) in the 7MM to increase to 204,424 cases by 2027, at an AGR...

  • Eating Disorder
  • World
  • Prescription Drug Sales
  • Cancer Mortality

Fighting the stigma: Rising awareness of eating disorders will boost demand for clinics Abstract Eating Disorder Clinics The Eating Disorder Clinics industry has experienced robust consumer demand for industry services. While there has been a relatively high prevalence of eating disorders,...

  • Eating Disorder
  • United States
  • Employment Income
  • Disposable Income

Binge Eating Disorder ongoing clinical trials report provides comprehensive analysis and trends in global Binge Eating Disorder disease clinical trials. The research work analyzes the ongoing Binge Eating Disorder clinical trial trends across countries and companies. The report focuses on drugs and therapies being evaluated for Binge...

  • Eating Disorder
  • Clinical Trial
  • World

This Market Spotlight report covers the Eating Disorders market, comprising key marketed and pipeline drugs, clinical trials, upcoming events, patent information, a 10-year disease prevalence forecast, and licensing and acquisition deals, as well as presenting drug-specific revenue forecasts.   Key Takeaways  Worldwide,...

  • Eating Disorder
  • Drug Approval

Omeros Corporation - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Omeros Corporation - Product Pipeline Review - 2016’, provides an overview of the Omeros Corporation’s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under...

  • Drug Development
  • Research And Development
  • Psychotic Disorder
  • Musculoskeletal Disorder
  • Arthritis
  • Lung Cancer
  • Cardiovascular Disease
  • Obesity
  • Mental Health
  • Eating Disorder
  • World
  • United States
  • Diagnostic Imaging Density
  • Food Consumption